April 9th 2024
Improving the site-sponsor relationship can get trials off on the right foot and on a path for success.
January 19th 2024
With variation in costs between different stakeholders in clinical trials, there is often disagreement on fair market value.
December 29th 2023
Authors highlighted outsourcing and the impact of the COVID-19 pandemic in these CRO/sponsor articles from 2023.
December 22nd 2023
Can full-service outsourcing to CROs by large biopharma companies sustainably prosecute a clinical development portfolio?
November 17th 2023
A shared partnership culture is critical in navigating today’s complex terrain.
Optimizing Efficiency
Oncology clinical trials: A case for Russia and Eastern Europe.
Biomarker-Driven Oncology Trials
Accelerating the discovery and delivery of personalized medicine.
Maximizing Oncology Imaging Data
Increasing development costs and high failure rates require earlier integration of imaging data in the Phase I setting.
Patient-First Approach to Improve Oncology Clinical Trials
Life can change in an instant, but there is one thing that always abides: hope.
DIY EDC Evaluation
Options have emerged that make DIY EDC technology more accessible to smaller organizations.
Clinical Trials in the Baltic States
The region has an appropriate population size, solid infrastructure, experienced nvestigators, and short timelines.
Leading Clinical Projects
A survey of clinical research professionals asked: What makes you a successful project leader?
Outsourcing: China Takes Center Stage
Conversion from paper to ePRO for an instrument designed to assess diabetes' impact on quality of life.
Model Assisted Drug Development
Modeling and simulation has been heralded for some time as a possible answer to the industry's woes.
Implications of Biosimilar Development
Demonstrating biosimilarity is highly dependent on the unique characteristics of the product.
Global Supply Chain Management
From tactical to strategic: tracking the evolution of global clinical supply chain management.
Clinical Trial Community Portals
A well designed CTCP can keep everyone motivated and focused on achieving trial objectives.
CRO Timeline 1981-2012
The major industry milestones of the past 20 years.
Are Phase Labels Still Relevant?
The adoption of new, consistent definitions are needed to help demystify late phase trials.
Outsourcing Landscape
Continual change is coming as sponsors' sourcing requirements diverge from the major CROs.
What to Know About CROs
Where do CRO's turn next? What does pharma do about it?
Recruitment Drivers
Cancer trial recruitment is struggling-adult participation is limited.
Early Phase Trials
Optimizing early phase trials key to the success of novel cytotoxics and targeted therapies.
A Data Driven Approach
Are emerging markets the only answer to oncology clinical trial recruitment?
HIV Vaccine Trials: Safe for All
Researchers who work on HIV vaccines face a major challenge: convincing members of at-risk communities to volunteer for these trials.
Enrollment: More Than Numbers
Partnering with CROs and using a blinded independent central review can increase trial success.
Emerging Opportunity in Guatemala
Guatemala is multi-ethnic, multilingual, and multi-cultural-ideal for international trials.
Predicting Successful Site Performance
Research shows four factors best predict successful patient enrollment in clinical trials.
BRIC Countries Contribute to Research
BRIC governements are working to make it easier to conduct trials in country.
Here Comes the Sun(shine Act)
Drug, biological supply, and medical device manufacturers must track all payments of over $10.
In Pursuit of Enlightenment
Knowledge is power, but power is of no value if you don't exercise it.
Clinical Contracting Efficiency
A simple but overlooked way to save millions of dollars during new drug development.
Eyes Play a Focal Role in Research
Two unique techniques help characterize pharmacodynamic drug effects in healthy subjects.